Impel NeuroPharma’s drug-device combo product nabs FDA nod for migraine
The FDA approved an Impel NeuroPharma migraine treatment, a nasal spray intended to bring pain relief more quickly than drugs administered in other ways. It marks the first approval for the Seattle company, which has developed a proprietary nasal delivery technology.